Research
Hormonal
Curcumin supplementation (1g/day with piperine) improves metabolic markers like triglycerides and inflammatory cytokines in obese individuals, though it does not significantly change body weight or BMI.
Take 1g of curcumin with 5mg of piperine daily for 30 days to improve triglyceride levels and reduce inflammation. Do not expect weight loss, as studies show no change in BMI or body fat.
ModerateQualifiesMEDIUM confidence
In this study, obese subjects were treated with a commercial formulation of curcumin (C3 Complex®, 1 g/day) supplemented with a bioavailability enhancer, piperine (5 mg/day) for a month. Although there were no changes in weight, body mass index (BMI), or body fat, serum triglyceride levels were significantly decreased after curcumin treatment, indicating the improvement of insulin actions [68].
Why this rating
Based on small clinical trials (n=2 cited) with mixed results on body composition.
Source
The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity
Yueshui Zhao et al. · Oxidative Medicine and Cellular Longevity · 2017
DOI 10.1155/2017/1459497
narrative_reviewCited 208×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Quercetin supplementation (100-150 mg/day) significantly reduces body fat percentage and BMI in overweight or obese adults, likely by modulating adipokine expression and oxidative stress.Moderate
- Resveratrol (150 mg/day) increases energy expenditure and reduces inflammatory markers in obese men, but higher doses (1500 mg/day) may be ineffective for these outcomes.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →